CEO, PneumaCare

Mark Harwood is the CEO of PneumaCare, a Cambridge based company developing and marketing revolutionary non-contact, non-invasive respiratory imaging systems that allow the user to better understand respiratory function. Founded in 2009, the company’s initial focus was centred on the clinical need for better lung function assessment in children. Since that time, PneumaCare has expanded this focus to include adults in the lung function, ICU and thoracic surgery segments.

Previously Mark was President and CEO of ArjoHuntleigh and Vice President of Baxter International Inc (Global) in the US. He moved on to become President of RF Technologies (North America & EMEA) based in the US. He has also gained extensive experience outside of the US, as Managing Director for Arjo Med AB, UK & Ireland.